Skip to content
Back to resident companies

GRO Biosciences

Investment areas

  • Biotech / Life Sciences
Founders & Leadership
Dan Mandell
Chris Gregg
Ben Stranges
Headquarters
Cambridge, MA

Redefining protein therapeutics.

The Tough Tech problem we are solving

We’re striving to fulfill the promise of protein-based therapies by reprogramming biology.

About our solution

Our GRO platform creates novel proteins with an expanded alphabet of non-standard amino acids (NSAAs), providing therapeutic modalities that were previously impossible. Our production process is scalable, stable, and sustainable.